Bioinformatic prediction and identification of immunogenic epitopes of the antigenic 14-3-3 protein of Echinococcus multilocularis.


Journal

Acta tropica
ISSN: 1873-6254
Titre abrégé: Acta Trop
Pays: Netherlands
ID NLM: 0370374

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 13 09 2020
revised: 30 04 2021
accepted: 04 05 2021
pubmed: 13 5 2021
medline: 25 6 2021
entrez: 12 5 2021
Statut: ppublish

Résumé

Alveolar echinococcosis is a high-risk parasitic disease caused by the larval stage of Echinococcus multilocularis. The study aimed to predict and identify the dominant Th1/Th2 and B cell epitopes of the antigen protein 14-3-3 beta:alpha from Echinococcus multilocularis. A comparison of the four amino acid sequences of 14-3-3 beta:alpha was respectively derived from Echinococcus multilocularis, Rattus norvegicus, Canis lupus familiaris, and Homo sapiens was carried out by CLUSTALW to provide a basis for excluding similar epitopes. The amino acid sequence information was analyzed by SOPMA and the homology model was established by Swiss-Model. IEDB and SYFPEITHI were used to predict T cell epitopes. According to the Bcepred and ABCpred, the B cell epitopes were comprehensively predicted and analyzed. The dominant epitopes were validated by Lymphocyte Proliferation, ELISA, ELISpot, and Flow cytometry. Eight potential epitopes of 14-3-3 from Echinococcus multilocularis were screened according to the results of prediction and analysis: 14-3-3 In this study, two dominant antigen epitopes of B cells, two Th1 dominant antigen epitopes, and one Th2 dominant antigen epitope were validated. Our work provides a basis for the subsequent development of efficient and safe vaccines targeting epitopes of Echinococcus multilocularis.

Identifiants

pubmed: 33979643
pii: S0001-706X(21)00134-0
doi: 10.1016/j.actatropica.2021.105955
pii:
doi:

Substances chimiques

14-3-3 Proteins 0
Epitopes, B-Lymphocyte 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105955

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Wei Wei (W)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China; Qinghai-Utah Joint Research Key Lab for High Altitude Medicine, Kunlun Road, Xining 810001, Qinghai, China.

Lei Wang (L)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China; Basic Medicine Department, Qinghai University, Xining 810001, China.

Pei Zhou (P)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China; Basic Medicine Department, Qinghai University, Xining 810001, China.

Baili Jiang (B)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China.

Haisheng Liu (H)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China.

Lin Feng (L)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China; Basic Medicine Department, Qinghai University, Xining 810001, China.

Ri-Li Ge (RL)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China; Qinghai-Utah Joint Research Key Lab for High Altitude Medicine, Kunlun Road, Xining 810001, Qinghai, China.

Feng Tang (F)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China; Qinghai-Utah Joint Research Key Lab for High Altitude Medicine, Kunlun Road, Xining 810001, Qinghai, China. Electronic address: leileitang1984@163.com.

Runle Li (R)

Research Center for High Altitude Medicine, Qinghai University, Kunlun Road, Xining 810001, Qinghai, China; Qinghai-Utah Joint Research Key Lab for High Altitude Medicine, Kunlun Road, Xining 810001, Qinghai, China; Basic Medicine Department, Qinghai University, Xining 810001, China. Electronic address: aprilmomoa@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH